Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

T.L. Laursen; K. Kazankov; T.D. Sandahl; H.J. Møller; L. Hagelskjær Kristensen; C. Holmboe; C. Sølund; H. Arildsen; A. Laursen; H. Grønbæk

doi:10.1016/S0168-8278(18)31339-4

Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

T.L. Laursen
, K. Kazankov
, T.D. Sandahl
, H.J. Møller
, L. Hagelskjær Kristensen
, C. Holmboe
, C. Sølund
, H. Arildsen
, A. Laursen
, H. Grønbæk

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	FRI-399
Journal	Journal of Hepatology
Volume	68
Issue number	Suppl. 1
Pages (from-to)	S541
ISSN	0168-8278
DOIs	https://doi.org/10.1016/S0168-8278(18)31339-4
Publication status	Published - Apr 2018
Event	The International Liver Congress 2018 - Paris, France Duration: 11 Apr 2018 → 15 Apr 2018

Conference

Conference	The International Liver Congress 2018
Country/Territory	France
City	Paris
Period	11/04/2018 → 15/04/2018

Access to Document

10.1016/S0168-8278(18)31339-4

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Laursen, T. L., Kazankov, K., Sandahl, T. D., Møller, H. J., Hagelskjær Kristensen, L., Holmboe, C., Sølund, C., Arildsen, H., Laursen, A., & Grønbæk, H. (2018). Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients. Journal of Hepatology, 68(Suppl. 1), S541. Article FRI-399. https://doi.org/10.1016/S0168-8278(18)31339-4

@article{782121c133a8427c98414cf642358394,

title = "Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients",

author = "T.L. Laursen and K. Kazankov and T.D. Sandahl and H.J. M{\o}ller and \{Hagelskj{\ae}r Kristensen\}, L. and C. Holmboe and C. S{\o}lund and H. Arildsen and A. Laursen and H. Gr{\o}nb{\ae}k",

year = "2018",

month = apr,

doi = "10.1016/S0168-8278(18)31339-4",

language = "English",

volume = "68",

pages = "S541",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier",

number = "Suppl. 1",

note = "The International Liver Congress 2018 ; Conference date: 11-04-2018 Through 15-04-2018",

}

Laursen, TL, Kazankov, K, Sandahl, TD, Møller, HJ, Hagelskjær Kristensen, L, Holmboe, C, Sølund, C, Arildsen, H, Laursen, A & Grønbæk, H 2018, 'Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients', Journal of Hepatology, vol. 68, no. Suppl. 1, FRI-399, pp. S541. https://doi.org/10.1016/S0168-8278(18)31339-4

Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients. / Laursen, T.L.; Kazankov, K.; Sandahl, T.D. et al.
In: Journal of Hepatology, Vol. 68, No. Suppl. 1, FRI-399, 04.2018, p. S541.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

AU - Laursen, T.L.

AU - Kazankov, K.

AU - Sandahl, T.D.

AU - Møller, H.J.

AU - Hagelskjær Kristensen, L.

AU - Holmboe, C.

AU - Sølund, C.

AU - Arildsen, H.

AU - Laursen, A.

AU - Grønbæk, H.

PY - 2018/4

Y1 - 2018/4

U2 - 10.1016/S0168-8278(18)31339-4

DO - 10.1016/S0168-8278(18)31339-4

M3 - Conference abstract in journal

SN - 0168-8278

VL - 68

SP - S541

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - Suppl. 1

M1 - FRI-399

T2 - The International Liver Congress 2018

Y2 - 11 April 2018 through 15 April 2018

ER -